CV Lattes
ResearcherID
ORCID
Google Scholar Citations
Universidade de São Paulo (USP). Faculdade de Medicina (FM) (Institutional affiliation from the last research proposal) Birthplace: Brazil
graduation at Licenciatura Plena em Ciências e Biologia from Universidade Presbiteriana Mackenzie (2004), graduation at Biologia from Universidade Presbiteriana Mackenzie (2005) and doctorate at Fisiopatologia Renal from Faculdade de Medicina da Universidade de São Paulo (2011). Has experience in Physiology, focusing on Physiology, acting on the following subjects: imuno-histoquímica, imunologia, doença renal crônica, metaloproteinases and imunodiagnóstico. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Chronic kidney disease (CKD), characterized by the progressive and irreversible loss of kidney functions, is currently considered an importat global health issue, due to both its increasing incidence and its high morbidity and mortality.The therapeutic arsenal employed to the conservative management of human CKD is mostly based on the pharmacological blockade of the renin-angiotensin-aldo…
Chronic kidney disease (CKD) is a progressive, debilitating condition of high lethality, which prevalence have been increasing considerably in recent decades. Regardless of the etiology of CKD, the exacerbated activation of the renin-angiotensin-aldosterone system (RAAS), as well as the establishment of local renal inflammation, with engagement of both innate and adaptive mechanisms, extr…
Chronic Kidney Disease (CKD) is characterized by progressive loss of renal function, leading to the need for renal replacement therapy (RRT). Currently, the clinical management of CKD, which aims to slow disease progression and delay the need for RRT, is mainly based on pharmacological blockade of the renin-angiotensin-aldosterone system (RAAS) and inhibition of sodium-glucose cotransport…
The number of patients that underwent life-long renal replacement therapy due to renal failure caused by the progression of chronic kidney disease (CKD), has been progressively increasing in Brazil and worldwide. Of note, CKD is a debilitating condition, with high morbidity and mortality rates and it is extremely expensive for public and private health systems. The increase of life expect…
Chronic Kidney Disease (CKD) is characterized by the progressive and irreversible loss ofkidney functions. Currently, the therapeutic arsenal used to control CKD is limited toapplication of RAAS inhibitor drugs, diuretics and immunosuppressive drugs, eventuallyrelated to side effects. Recent data in the literature have shown that the application ofmesenchymal stem cells (MSC) in the kidne…
CChronic kidney disease (CKD) is considered a serious public health problem worldwide. It is characterized by progressive and irreversible renal function loss, that leads to the increase of systemic blood pressure, loss of the glomerular filtration barrier selectivity, renal inflammation and fibrosis, regardless of its etiology. Since there is still no therapeutic arsenal to effectively c…
| 1 / 0 | Ongoing grants |
| 4 / 3 | Completed research grants |
| 1 / 1 | Ongoing scholarships in Brazil |
| 3 / 3 | Completed scholarships in Brazil |
| 9 / 7 | All research grants and scholarships |
| Associated processes | |